Study to Evaluate Immunogenicity and Safety of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine at 9 and 10 Years After Vaccine Administration and Assessment of Re-vaccination With 2 Additional Doses at 10 Years After Initial Vaccination, in Healthy Subjects Aged 60 Years of Age(YOA) and Older
Clinical trial NCT02735915 · COMPLETED
Trial details
- NCT number
- NCT02735915
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-11
- Primary completion
- 2017-08-28
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.